a General Medicine Research Unit , Butler Hospital , Providence , Rhode Island , USA.
b Warren Alpert Medical School of Brown University , Providence , Rhode Island , USA.
Subst Abus. 2017 Oct-Dec;38(4):389-393. doi: 10.1080/08897077.2017.1353570. Epub 2017 Jul 10.
Without aftercare treatment, persons discharged from short-term inpatient detoxification for opioid use disorder are at high risk of relapse. In previous work, those who were recently homeless or had pending legal problems were more likely to prefer residential treatment for aftercare. Here, based on clinical experience, the authors hypothesize that a particular clinical factor, surviving an opioid overdose, will be associated with aftercare preference.
Between May and December 2015, the authors surveyed consecutive persons seeking inpatient opioid detoxification. To assess aftercare treatment preference, participants were asked, "If you had unlimited treatment options and all were free, which one would work best for you when you leave here?" To assess overdose history, participants were asked about overdose "since your first drug use," and "in the last year."
Participants' (N = 440) mean age was 32.3 (± 8.7) years; 70.7% were male. More than half (51.1%) of participants expressed an aftercare preference for medication-assisted treatment (MAT), 12.7% for outpatient counseling only, 10.7% for residential treatment,18.6% for no formal treatment (Narcotics Anonymous/Alcoholics Anonymous only or a halfway house), and 6.8% did not want any postdetoxification treatment. About 40% reported a history of overdose, and 24.8% reported past year overdose. In the multivariate model, treatment preference was associated with sex (P < .001), homelessness (P = .01), and history of drug overdose (P = .02).
Although MAT was preferred by the majority of participants, the experience of a nonfatal overdose was associated with the choice of residential treatment as postdetoxification treatment.
未经后续治疗,短期住院戒毒治疗后出院的阿片类药物使用障碍患者有很高的复发风险。在之前的研究中,最近无家可归或有未决法律问题的人更倾向于选择住院治疗作为后续治疗。在这里,基于临床经验,作者假设一个特定的临床因素,即阿片类药物过量存活,与后续治疗偏好相关。
在 2015 年 5 月至 12 月期间,作者对连续寻求住院阿片类药物戒毒的患者进行了调查。为了评估后续治疗的偏好,参与者被问到:“如果您有无限的治疗选择,并且都是免费的,那么在您离开这里时,哪一种对您最有效?”为了评估过量用药史,参与者被问到关于“自首次吸毒以来”和“去年”的过量用药情况。
参与者(N=440)的平均年龄为 32.3(±8.7)岁;70.7%为男性。超过一半(51.1%)的参与者表示对药物辅助治疗(MAT)有后续治疗偏好,12.7%的人只需要门诊咨询,10.7%的人需要住院治疗,18.6%的人不需要正式治疗(仅参加戒毒互助会/戒酒互助会或中途之家),6.8%的人不想接受任何戒毒后治疗。约 40%的人报告有过过量用药史,24.8%的人报告有过去一年的过量用药史。在多变量模型中,治疗偏好与性别(P<.001)、无家可归(P=.01)和药物过量史(P=.02)有关。
尽管大多数参与者都倾向于 MAT,但非致命性药物过量的经历与选择住院治疗作为戒毒后治疗有关。